BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29224132)

  • 41. Insulin Pump Settings During Breastfeeding in Women with Type 1 Diabetes.
    Nørgaard SK; Nørgaard K; Roskjær AB; Mathiesen ER; Ringholm L
    Diabetes Technol Ther; 2020 Apr; 22(4):314-320. PubMed ID: 31580150
    [No Abstract]   [Full Text] [Related]  

  • 42. Young children with type 1 diabetes can achieve glycemic targets without hypoglycemia: Results of a novel intensive diabetes management program.
    Phelan H; King B; Anderson D; Crock P; Lopez P; Smart C
    Pediatr Diabetes; 2018 Jun; 19(4):769-775. PubMed ID: 29504243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
    Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
    Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.
    Kovatchev BP; Renard E; Cobelli C; Zisser HC; Keith-Hynes P; Anderson SM; Brown SA; Chernavvsky DR; Breton MD; Mize LB; Farret A; Place J; Bruttomesso D; Del Favero S; Boscari F; Galasso S; Avogaro A; Magni L; Di Palma F; Toffanin C; Messori M; Dassau E; Doyle FJ
    Diabetes Care; 2014 Jul; 37(7):1789-96. PubMed ID: 24929429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-severe hypoglycemia in type 1 diabetes: a randomized crossover trial comparing two quantities of oral carbohydrates at different insulin-induced hypoglycemia ranges.
    Taleb N; Gingras V; Cheng R; Parent V; Messier V; Bovan D; Shohoudi A; Brazeau AS; Rabasa-Lhoret R
    Front Endocrinol (Lausanne); 2023; 14():1186680. PubMed ID: 37334295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: a randomized, placebo-controlled, crossover trial.
    Kalergis M; Schiffrin A; Gougeon R; Jones PJ; Yale JF
    Diabetes Care; 2003 Jan; 26(1):9-15. PubMed ID: 12502652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
    Choudhary P; Davies C; Emery CJ; Heller SR
    Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hypoglycemia in patients treated with an external insulin pump].
    Laurent JC; Waeber G; Ruiz J; Carron PN
    Rev Med Suisse; 2011 Jan; 7(278):166-9. PubMed ID: 21400952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.
    Gómez AM; Henao DC; Imitola A; Muñoz OM; Sepúlveda MAR; Kattah L; Guerrero JS; Morros E; Llano JP; Jaramillo MG; León-Vargas F
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Oct; 65(8):451-457. PubMed ID: 29914817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Predictive Low Glucose Management System in Prevention of Clinically Significant Hypoglycemia in Type 1 Diabetes. A Preliminary Study Identifying the Most Common Events Leading Up to Hypoglycemia During Insulin Pump Therapy.
    Thomakos P; Mitrakou A; Kepaptsoglou O; Taraoune I; Barreto C; Zoupas CS
    Exp Clin Endocrinol Diabetes; 2021 May; 129(5):385-389. PubMed ID: 30986882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study.
    Ranjan A; Schmidt S; Damm-Frydenberg C; Steineck I; Clausen TR; Holst JJ; Madsbad S; Nørgaard K
    Diabetes Care; 2017 Jan; 40(1):132-135. PubMed ID: 27797928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin pump patient characteristics and glucose control in the hospitalized setting.
    Kannan S; Satra A; Calogeras E; Lock P; Lansang MC
    J Diabetes Sci Technol; 2014 May; 8(3):473-8. PubMed ID: 24876608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recommendations for recognizing, risk stratifying, treating, and managing children and adolescents with hypoglycemia.
    Zucchini S; Tumini S; Scaramuzza AE; Bonfanti R; Delvecchio M; Franceschi R; Iafusco D; Lenzi L; Mozzillo E; Passanisi S; Piona C; Rabbone I; Rapini N; Rigamonti A; Ripoli C; Salzano G; Savastio S; Schiaffini R; Zanfardino A; Cherubini V
    Front Endocrinol (Lausanne); 2024; 15():1387537. PubMed ID: 38894740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No Disadvantage to Insulin Pump Off vs Pump On During Intermittent High-Intensity Exercise in Adults With Type 1 Diabetes.
    Zaharieva DP; Cinar A; Yavelberg L; Jamnik V; Riddell MC
    Can J Diabetes; 2020 Mar; 44(2):162-168. PubMed ID: 31416695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Individual glucose responses to prolonged moderate intensity aerobic exercise in adolescents with type 1 diabetes: The higher they start, the harder they fall.
    Riddell MC; Zaharieva DP; Tansey M; Tsalikian E; Admon G; Li Z; Kollman C; Beck RW
    Pediatr Diabetes; 2019 Feb; 20(1):99-106. PubMed ID: 30467929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.